The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,612,477 in first-year total cost, median $2,306,239.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-N (O1)]2
Most frequent institutions
- JOSLIN DIABETES CENTER2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Search for biomarkers to measure progression of diabetic nephropathy in Type 1 diabetes; application of proteomics technologies1DP3DK112177-01 | GALECKI, ANDRZEJ TKROLEWSKI, ANDRZEJ S | JOSLIN DIABETES CENTER, MA | $2,340,294 | ZDK1 |
| 2016 | Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy1DP3DK112192-01 | KING, GEORGE L | JOSLIN DIABETES CENTER, MA | $2,272,183 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.